Dr. Gilligan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
CA-60
Cleveland, OH 44195Phone+1 216-444-0391Fax+1 216-636-9286
Summary
- I am a medical oncologist specializing in testis cancer and other genitourinary malignancies. I currently chair the Testicular Cancer guideline panel at the National Comprehensive Cancer Network. A major focus of my work is teaching communication-skills to clinicians, as well as training others to teach communication skills. At the Cleveland Clinic, I helped develop and served on the leadership team of the Center for Excellence for Healthcare Communication where we have trained over 8000 clinicians in fundamental healthcare communication skills and have trained over 50 clinicians as trainers. I will serve as President of the Academy on Communication in Healthcare (ACH) for 2023 and 2024, and I was previously co-directer of the ACH faculty training program. At the Cleveland Clinic Lerner College of Medicine, I am the Associate Director of the communication skills course for first and second year medical students. Recently my work has focused on increasing Diversity, Equity, and Inclusion in healthcare and I am currently the DEI Officer for Graduate Medical Education at Cleveland Clinic.
I have taught communication skills to clinicians at national and international conferences and meetings of major organizations including the ACGME, AAMC, IHI, ASCO, and ACH. In addition to relationship-centered communication skills, workshops that I have led have focused on coaching, conflict engagement, team-building and feedback.
I also work in graduate medical education. I was program director of the hematology/oncology fellowship at Cleveland Clinic for ten years and currently serve as DEI Officer for GME at Cleveland Clinic and vice-Chair for Education at the Clinic's Taussig Cancer Institute.
Education & Training
- Dana-Farber Cancer Institute1999 - 2001
- Brigham and Women's HospitalResidency, Internal Medicine, 1996 - 1999
- Stanford University School of MedicineClass of 1996
Certifications & Licensure
- OH State Medical License 2005 - 2027
- MA State Medical License 1998 - 2005
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow Academy on Communication in Healthcare, 2020
- Fellow American Society of Clinical Oncology, 2017
- Scholarship in Teaching Award Case Western Reserve School of Medicine, 2015
- Join now to see all
Publications & Presentations
PubMed
- Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab.Moshe C Ornstein, Laeth George, Wei Wei, C Marcela Diaz-Montero, Pat Rayman
Clinical Genitourinary Cancer. 2024-12-01 - Knuckleheads.Timothy D Gilligan
Journal of Clinical Oncology. 2024-05-01 - 3 citationsSafety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation D...Amanda Nizam, Ryan K Rader, Alice Tzeng, Wei Wei, Iris Yeong-Fung Sheng
Clinical Genitourinary Cancer. 2024-04-01
Journal Articles
- The Association Between Facility Case Volume and Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy EraTimothy Gilligan, Jorge A Garcia, Brian I Rini, Urologic Oncology
- Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal TherapyVadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate
Books/Book Chapters
Lectures
- Patient-Clinician Communication: Implementing the New ASCO Consensus Guideline.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- Risk stratification of metastatic testicular germ cell tumorsGilligan TD
http://www.uptodate.com/contents/risk-stratification-of-metastatic-testicular-germ-cell-tumors
UpToDate, Wolters Kluwer Health - 2012-10-11 - Nonurothelial bladder cancerGilligan TD, Hayes JH
http://www.uptodate.com/contents/nonurothelial-bladder-cancer
UpToDate, Wolters Kluwer Health - 2012-03-13 - Small cell carcinoma of the bladderGilligan TD
http://www.uptodate.com/contents/small-cell-carcinoma-of-the-bladder
UpToDate, Wolters Kluwer Health - 2012-11-12 - Join now to see all
Authored Content
- Trespass and Forgiveness9/16/2018
- The Dangerous Intimacy of Life8/23/2018
- Blind Spots8/15/2018
- The Power of Questions8/7/2018
- Communication as Performance8/1/2018
- Join now to see all
Press Mentions
- Do Brain Metastases Rule Out Immunotherapy in RCC?June 11th, 2019
- Patient Outcomes for Atezolizumab vs Sunitinib in Renal Cell CarcinomaJune 10th, 2019
- Effect of Anti-Angiogenesis/Immunotherapy Combo in Poor-Risk RCCJune 10th, 2019
- Join now to see all
Professional Memberships
- American Society of Clinical OncologyFellow
- Academy on Communication in HealthcareBoard Member
- Academy on Communication in HealthcareFaculty
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: